A new type of drug that has been developed to treat lung disease has been found to cure diabetes amongst mice.
The conclusion was gleaned from two teams of US researchers who found that AAT (Alpha1-antitypsin) could help insulin -producing cells to survive, and even cured diabetes in animal trials.
Furthermore, the teams claim that the results have serious implications for people with type 1 diabetes . Charles Dinarello, an expert from the University of Colorado Health Sciences Center in Denver, reportedly commented: “Because AAT treatment in humans is safe, its use during human (trials) may be considered.”
At this stage, AAT is not widely available, but experts throughout the world have already expressed interest and hopes that the study results could quickly become a diabetic treatment reality.

Get our free newsletters

Stay up to date with the latest news, research and breakthroughs.

You May Also Like

Type 2 diabetes found to be a ‘significant risk factor’ among stroke victims

More evidence has been published which supports that diabetes is a “significant…

Conversation about doctors’ appointments occurring virtually rumbles on

More than half of GP appointments are still being delivered remotely in…

Top diabetes professor drafts risk assessment document for frontline COVID-19 staff

The health and wellbeing of frontline NHS staff has been prioritised among…